These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22762421)

  • 1. Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy?
    Lawn SD; Wood R
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):995-6. PubMed ID: 22762421
    [No Abstract]   [Full Text] [Related]  

  • 2. A new tool for monitoring isoniazid preventive therapy.
    Eisenhut M
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):424. PubMed ID: 23407235
    [No Abstract]   [Full Text] [Related]  

  • 3. Scale-up of isoniazid preventive therapy in PEPFAR-assisted clinical sites in South Africa.
    Bristow CC; Larson E; Vilakazi-Nhlapo AK; Wilson M; Klausner JD
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1020-2. PubMed ID: 22668595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study.
    Marx FM; Yaesoubi R; Menzies NA; Salomon JA; Bilinski A; Beyers N; Cohen T
    Lancet Glob Health; 2018 Apr; 6(4):e426-e435. PubMed ID: 29472018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of isoniazid preventive therapy for HIV-infected adults: overstatement of district reports.
    Martinson NA; McLeod KE; Milovanovic M; Msandiwa R; Lebina L
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):1005. PubMed ID: 25199022
    [No Abstract]   [Full Text] [Related]  

  • 6. Erring on the side of action: time for HIV programmes to implement isoniazid preventive therapy.
    Granich R; Getahun H; Reid A; Raviglione M; De Cock KM
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):925-6. PubMed ID: 19723370
    [No Abstract]   [Full Text] [Related]  

  • 7. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
    Golub JE; Pronyk P; Mohapi L; Thsabangu N; Moshabela M; Struthers H; Gray GE; McIntyre JA; Chaisson RE; Martinson NA
    AIDS; 2009 Mar; 23(5):631-6. PubMed ID: 19525621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of isoniazid preventive therapy in South Africa, 2011.
    Chehab JC; Vilakazi-Nhlapo K; Vranken P; Peters A; Klausner JD
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):903-7. PubMed ID: 22583688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
    Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A;
    Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
    Frigati LJ; Kranzer K; Cotton MF; Schaaf HS; Lombard CJ; Zar HJ
    Thorax; 2011 Jun; 66(6):496-501. PubMed ID: 21460373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia.
    Foster S; Godfrey-Faussett P; Porter J
    AIDS; 1997 Jun; 11(7):919-25. PubMed ID: 9189218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The point of view of a high prevalence country: Malawi.
    Nyangulu DS
    Bull Int Union Tuberc Lung Dis; 1991 Dec; 66(4):173-4. PubMed ID: 1687509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis preventive therapy for HIV-infected persons in less developed countries.
    Kritski AL
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S76-81. PubMed ID: 10688154
    [No Abstract]   [Full Text] [Related]  

  • 14. Mortality benefit of isoniazid preventive therapy in HIV-positive persons: a simulation study.
    Bachhuber MA; Gross R
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):1038-40. PubMed ID: 19723386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid preventive therapy use among patients on antiretroviral therapy: a missed opportunity.
    Kufa T; Chihota VN; Charalambous S; Churchyard GJ
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):312-4. PubMed ID: 24670568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.
    Grant AD; Charalambous S; Fielding KL; Day JH; Corbett EL; Chaisson RE; De Cock KM; Hayes RJ; Churchyard GJ
    JAMA; 2005 Jun; 293(22):2719-25. PubMed ID: 15941800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the performance of isoniazid preventive therapy for reducing tuberculosis in HIV endemic settings: the effects of network structure.
    Mills HL; Cohen T; Colijn C
    J R Soc Interface; 2011 Oct; 8(63):1510-20. PubMed ID: 21508012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid preventive therapy for HIV-infected people: evidence to support implementation.
    Eldred LJ; Churchyard G; Durovni B; Godfrey-Faussett P; Grant AD; Getahun H; Chaisson RE
    AIDS; 2010 Nov; 24 Suppl 5():S1-3. PubMed ID: 21079422
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of Tuberculosis after Routine IPT (Isoniazid Preventive Therapy) in HIV Infected Patients at a Tertiary Center.
    Panwar P; Maurya SC; Nag RK; Srivastava SK; Chowdhary S
    J Assoc Physicians India; 2020 Jan; 68(1):77. PubMed ID: 31979757
    [No Abstract]   [Full Text] [Related]  

  • 20. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study.
    Lester R; Hamilton R; Charalambous S; Dwadwa T; Chandler C; Churchyard GJ; Grant AD
    AIDS; 2010 Nov; 24 Suppl 5():S45-8. PubMed ID: 21079427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.